Neutrons and Sudden Cardiac Death (SCD)-Codes 121-125 ICD 10

2006 ◽  
Vol 17 (1) ◽  
Author(s):  
Ε. Stoupel ◽  
S. Domarkiene ◽  
R. Radishauskas ◽  
E. Abramson ◽  
P. Israelevich ◽  
...  
Keyword(s):  
Sudden Cardiac Death ◽  
Cardiac Death ◽  
Icd 10

scholarly journals Hypereosinophilic Syndrome, Cardiomyopathies, and Sudden Cardiac Death in Superinvasive Opisthorchiasis

2019 ◽  
Vol 2019 ◽  
pp. 1-5 ◽  
Author(s):  
Vitaly G. Bychkov ◽  
Vladimir M. Zolotukhin ◽  
Elena D. Khadieva ◽  
Svetlana V. Kulikova ◽  
Ivan M. Petrov ◽  
...  
Keyword(s):  
Sudden Cardiac Death ◽  
Heart Muscle ◽  
Cardiac Death ◽  
Myocardial Metabolism ◽  
Hypereosinophilic Syndrome ◽  
Cardiovascular Pathology ◽  
Healthcare Facilities ◽  
Icd 10

Cardiovascular pathology in patients with superinvasive opisthorchiasis is characterized by severe changes in haemodynamics and myocardial metabolism, impaired automatism, excitability, and conduction of the heart muscle. An analysis of 578 cases (medical and outpatient records and reports of pathoanatomical and forensic autopsies) recorded in healthcare facilities treating opisthorchiasis patients with a hyperendemic focus was carried out. We identified a set of cardiac changes in patients with hypereosinophilic syndrome associated with superinvasive opisthorchiasis infection, classified the pathological processes in accordance with ICD-10, and described their pathogenesis.

scholarly journals 2017-2019 Sudden cardiac death registry of the Zabaykalsky Krai population (ZODIAC)

2020 ◽  
Vol 25 (11) ◽  
pp. 3997
Author(s):  
D. N. Zaitsev ◽  
P. V. Vasilenko ◽  
A. V. Govorin ◽  
E. A. Vasilenko ◽  
N. V. Mukha ◽  
...  
Keyword(s):  
Sudden Cardiac Death ◽  
Ethyl Alcohol ◽  
Cardiac Death ◽  
Age Groups ◽  
Statistical Processing ◽  
Decompensated Heart Failure ◽  
Blood Alcohol ◽  
Icd 10 ◽  
Coronary Syndromes ◽  
The Mean

Aim. Based on the autopsy data, to analyze mortality patterns of the Zabaykalsky Krai population over a three-year period in the group of out-of-hospital sudden cardiac death (SCD).Material and methods. The protocols of deceased persons without evidence for violent death were analyzed with distribution into groups depending on age, sex and cause of death. Descriptive statistics were used for statistical processing.Results. The leading positions (58% of cases) in mortality patterns are occupied by various types of coronary artery disease (CAD). Chronic coronary syndromes were detected in 21%, cardiomyopathy — in 11%, decompensated heart failure — in 7%, myocarditis — in 1% of cases. Acute types of CAD were found in 68,4% in men and 31,6% in women. Among men, the number of such cases increases from 31 to 70 years of age and decreases over 70 years old. Among women, there is an increase in the SCD prevalence in the group over 70 years old.Chronic coronary syndromes were found in 46,4% in men and 53,6% in women. In both groups the number of cases increases with age. The maximum sex differences are observed in the group over 70 years old. The mean age for men is 72,2±8,8 years, for women — 77,2±10,4 years. Blood alcohol was detected in 10,2% of cases. The mean age of the deceased in all age groups of persons with identified blood alcohol was 66,2±12 years.In 1,89% of cases, I46 code (ICD-10) was established. The largest number of deaths among persons of both sexes was registered in the group of 31-40 years old, accounting for 36,8% among men and 13,2% among women. The mean age of the deceased was 35,8±8,4 years. In 28,6% of cases, ethyl alcohol was found in the biological media of the deceased in this group.Conclusion. Acute and chronic types of CAD make a significant contribution to out-of-hospital mortality. The number of SCD in men is higher than in women and is directly proportional to the age increase, reaching a maximum in the group over 70 years old. Ethyl alcohol, an important trigger of SCD, was detected in 10,8% of SCD cases in 2017, and in 15% in 2018 and 2019.

Overexpression of the transcription factor Hand1 causes sudden cardiac death in mice

2008 ◽  
Vol 7 ◽  
pp. 109-109
Author(s):  
R BRECKENRIDGE ◽  
Z ZUBERI ◽  
L FELKIN ◽  
E BIRKS ◽  
P BARTON ◽  
...  
Keyword(s):  
Transcription Factor ◽  
Sudden Cardiac Death ◽  
Cardiac Death

Hypertrophe Kardiomyopathie: Definition, klinische Präsentation, Risikostratifizierung für den plötzlichen Herztod und Therapieoptionen

2016 ◽  
Vol 73 (12) ◽  
pp. 759-765
Author(s):  
Bettina Muggli ◽  
Christiane Gruner
Keyword(s):  
Sudden Cardiac Death ◽  
Cardiac Death ◽  
Hypertrophe Kardiomyopathie ◽  
Linksventrikuläre Hypertrophie ◽  
Orale Antikoagulation ◽  
Diastolische Dysfunktion ◽  
Icd Implantation ◽  
Elektrische Kardioversion ◽  
Systemische Erkrankungen

Zusammenfassung. Die hypertrophe Kardiomyopathie (HCM) ist die häufigste hereditäre Kardiomyopathie und wird definiert durch eine unerklärte linksventrikuläre Hypertrophie mit normal grossen Ventrikeln ohne andere kardiale Ursachen oder systemische Erkrankungen. Die klinische Präsentation ist vielfältig und reicht vom asymptomatischen Familienmitglied bis hin zu Patienten mit Symptomen einer schweren Herzinsuffizienz. Häufige Probleme sind der plötzliche Herztod (’sudden cardiac death’ SCD) und die Risikostratifizierung der Patienten im Hinblick auf eine primärprophylaktische ICD-Implantation. Des Weiteren spielen natürlich die Obstruktion des linksventrikulären Ausflusstrakts und deren Behandlung (medikamentös, kathetertechnisch mittels Septalalkoholablation, chirugische Myektomie), diastolische Dysfunktion, Vorhofflimmern und die Entwicklung einer Herzinsuffizienz mit systolischer linksventrikulärer Dysfunktion eine wichtige Rolle bei der Betreuung von Patienten mit HCM. Beim Vorhofflimmern muss unabhängig vom CHA2DS2Vasc Score eine orale Antikoagulation begonnen werden und aufgrund der diastolischen Dysfunktion sollte wenn möglich wieder ein Sinusrhythmus erreicht werden durch medikamentöse Massnahmen, elektrische Kardioversion und / oder Pulmonalvenenisolation. Kommt es zur Entwicklung einer Herzinsuffizienz ist eine übliche Herzinsuffizienztherapie indiziert. Bei terminaler Herzinsuffizienz sollte frühzeitig eine Herztransplantation evaluiert werden.

Sign in / Sign up

Export Citation Format

Share Document